Literature DB >> 14642819

Cyclin-dependent kinase 11(p110) activity in the absence of CK2.

Nancy A Sachs1, Richard R Vaillancourt.   

Abstract

Cyclin-dependent kinase (CDK)11(p110), formerly known as PITSLRE, is a serine/threonine kinase whose catalytic activity has been associated with transcription and RNA processing. To further evaluate the regulation of CDK11(p110) catalytic activity, interacting proteins were identified by liquid chromatography and tandem mass spectrometry (LC-MS/MS). Following the immunoprecipitation of CDK11(p110) from COS-7 cells, the serine/threonine kinase CK2 was identified by LC-MS/MS. These results were extended through the observation that CDK11(p110) serves as a substrate for CK2 and the identification of a phosphorylation site on CDK11(p110) at Ser227 by LC-MS/MS. To obtain CDK11(p110) devoid of CK2, CDK11(p110) was expressed in High Five insect cells and secreted into the media due to the presence of a honeybee melittin signal sequence encoded at the amino-terminus of CDK11(p110). Recombinant CDK11(p110) was purified from the media and phosphorylation of histone H1 subsequently demonstrated. After demonstrating retention of CDK11(p110) kinase activity, it was evaluated for activity on the carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II (RNAP II), but only CK2 was found to phosphorylate the CTD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642819     DOI: 10.1016/j.bbagen.2003.10.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Maintenance of genome stability: the unifying role of interconnections between the DNA damage response and RNA-processing pathways.

Authors:  B Mikolaskova; M Jurcik; I Cipakova; M Kretova; M Chovanec; L Cipak
Journal:  Curr Genet       Date:  2018-03-01       Impact factor: 3.886

2.  7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription.

Authors:  B Matija Peterlin; John E Brogie; David H Price
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-08-18       Impact factor: 9.957

3.  CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).

Authors:  H-H Choi; H-K Choi; S Y Jung; J Hyle; B-J Kim; K Yoon; E-J Cho; H-D Youn; J M Lahti; J Qin; S-T Kim
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

4.  CDK11 Promotes Cytokine-Induced Apoptosis in Pancreatic Beta Cells Independently of Glucose Concentration and Is Regulated by Inflammation in the NOD Mouse Model.

Authors:  Ester Sala; Celia Vived; Júlia Luna; Noemí Alejandra Saavedra-Ávila; Upasana Sengupta; A Raúl Castaño; Sabrina Villar-Pazos; Laura Haba; Joan Verdaguer; Ana B Ropero; Thomas Stratmann; Javier Pizarro; Manuel Vázquez-Carrera; Angel Nadal; Jill M Lahti; Conchi Mora
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

Review 5.  The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma.

Authors:  Johannes Tobias Thiel; Adrien Daigeler; Jonas Kolbenschlag; Katarzyna Rachunek; Sebastian Hoffmann
Journal:  Cancers (Basel)       Date:  2022-07-12       Impact factor: 6.575

Review 6.  The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.

Authors:  Yubing Zhou; Jacson K Shen; Francis J Hornicek; Quancheng Kan; Zhenfeng Duan
Journal:  Oncotarget       Date:  2016-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.